APA (7th ed.) Citation

Blommestein, H., Issa, D., Pompen, M., Révil, C., Hoogendoorn, M., Joosten, P., . . . Uyl-de Groot, C. (2012). PCN68 Pharmacoeconomic Evaluation of Rituximab as Maintenance Treatment for Relapsed Follicular Lymphoma: Results of a Real-World Population Based Study. Value in Health, 15(7), A421. https://doi.org/10.1016/j.jval.2012.08.2108

Chicago Style (17th ed.) Citation

Blommestein, H., D. Issa, M. Pompen, C. Révil, M. Hoogendoorn, P. Joosten, P. Huijgens, and C. Uyl-de Groot. "PCN68 Pharmacoeconomic Evaluation of Rituximab as Maintenance Treatment for Relapsed Follicular Lymphoma: Results of a Real-World Population Based Study." Value in Health 15, no. 7 (2012): A421. https://doi.org/10.1016/j.jval.2012.08.2108.

MLA (9th ed.) Citation

Blommestein, H., et al. "PCN68 Pharmacoeconomic Evaluation of Rituximab as Maintenance Treatment for Relapsed Follicular Lymphoma: Results of a Real-World Population Based Study." Value in Health, vol. 15, no. 7, 2012, p. A421, https://doi.org/10.1016/j.jval.2012.08.2108.